As of 2025-04-21, the Relative Valuation of Crescita Therapeutics Inc (CTX.TO) is (0.38) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.59 CAD, the upside of Crescita Therapeutics Inc based on Relative Valuation is -164.4%.
The range of the Relative Valuation is (0.43) - (0.39) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 3.0x - 4.4x | 3.7x |
| Forward P/E multiples | 0.4x - 2.7x | 1.6x |
| Fair Price | (0.43) - (0.39) | (0.38) |
| Upside | -172.6% - -165.7% | -164.4% |
| Date | P/E |
| 2025-04-16 | -4.08 |
| 2025-04-15 | -4.15 |
| 2025-04-14 | -4.01 |
| 2025-04-09 | -3.66 |
| 2025-04-07 | -3.73 |
| 2025-04-02 | -3.87 |
| 2025-04-01 | -4.01 |
| 2025-03-31 | -4.01 |
| 2025-03-28 | -4.01 |
| 2025-03-25 | -4.01 |
| 2025-03-24 | -4.08 |
| 2025-03-21 | -3.87 |
| 2025-03-17 | -3.59 |
| 2025-03-12 | -3.53 |
| 2025-03-10 | -3.80 |
| 2025-03-06 | -3.80 |
| 2025-03-05 | -4.08 |
| 2025-03-04 | -3.94 |
| 2025-03-03 | -3.94 |
| 2025-02-27 | -3.87 |
| 2025-02-25 | -3.87 |
| 2025-02-21 | -3.87 |
| 2025-02-19 | -3.87 |
| 2025-02-18 | -3.87 |
| 2025-02-14 | -3.94 |
| 2025-02-13 | -3.94 |
| 2025-02-10 | -3.80 |
| 2025-02-07 | -3.80 |
| 2025-02-06 | -4.08 |
| 2025-02-05 | -4.15 |
| 2025-02-04 | -4.15 |
| 2025-02-03 | -3.87 |
| 2025-01-31 | -3.94 |
| 2025-01-30 | -3.94 |
| 2025-01-29 | -4.01 |
| 2025-01-28 | -4.08 |
| 2025-01-27 | -4.01 |
| 2025-01-24 | -4.01 |
| 2025-01-23 | -4.01 |
| 2025-01-22 | -3.94 |
| 2025-01-21 | -4.01 |